BS
Binaya Sharma
About Binaya Sharma
Data last updated:
Binaya Sharma has 4 years in corporate governance. Holds Director role. Currently with 2 companies, including Icc Global Support Center Private Limited and Indrakeel Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Icc Global Support Center Private Limited at ₹3.81 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Mar 2022 | 2021 | ₹3.81 Cr (FY 2025) | Active | |
| Director | 26 Aug 2025 | 2025 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Binaya Sharma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Binaya Sharma
Binaya Sharma has 4 years in corporate governance. Holds Director role. Currently with 2 companies, including Icc Global Support Center Private Limited and Indrakeel Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Icc Global Support Center Private Limited at ₹3.81 Cr (FY 2025).
Binaya Sharma is associated with 2 companies as Director, including Icc Global Support Center Private Limited (₹3.81 Cr), Indrakeel Pharmaceuticals Private Limited.
Binaya Sharma has expertise in General Business.
Binaya Sharma has 4 years in corporate governance.
By reported revenue, the largest current company of Binaya Sharma is Icc Global Support Center Private Limited, with revenue of ₹3.81 Cr (FY 2025).
Binaya Sharma currently holds positions at 2 companies: Icc Global Support Center Private Limited (₹3.81 Cr), Indrakeel Pharmaceuticals Private Limited.